Coya Therapeutics Inc. (COYA) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Coya Therapeutics Inc.

    NASDAQ: COYA · Real-Time Price · USD
    6.10
    0.23 (3.92%)
    At close: Oct 03, 2025, 3:59 PM
    6.15
    0.82%
    After-hours: Oct 03, 2025, 04:10 PM EDT

    Coya Therapeutics Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -14.88M -7.99M -12.24M -4.89M
    Depreciation & Amortization
    		 27.36K 27.36K 27.36K 16.13K
    Stock-Based Compensation
    		 2.66M 872.25K 207.35K 233.22K
    Other Working Capital
    		 -6.1M 2.56M -93.45K 74K
    Other Non-Cash Items
    		 25K 543.19K 4.02M -399.68K
    Deferred Income Tax
    		 n/a n/a n/a 399.68K
    Change in Working Capital
    		 1.88M -4.64M 751.84K 739.17K
    Operating Cash Flow
    		 -10.29M -11.19M -7.24M -3.9M
    Capital Expenditures
    		 n/a n/a n/a -136.8K
    Cash Acquisitions
    		 n/a n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 -25K -543.19K -525K n/a
    Investing Cash Flow
    		 -25K -543.19K -525K -136.8K
    Debt Repayment
    		 n/a n/a 10.47M n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 2.02M 89.95K -1.11M -341.9K
    Financial Cash Flow
    		 16.03M 38.43M 9.36M -340.58K
    Net Cash Flow
    		 5.71M 26.69M 1.59M -4.38M
    Free Cash Flow
    		 -10.29M -11.19M -7.24M -4.04M

    Add to Watchlist